1.
纳入研究的一般特征
The characteristics of included
| Reference | Arm | Treatment schedule and dose | No. of patients | Age (yr) | PS | OS (wk) | 1-y SR (%) | ORR (%) |
| →: dose escalation; PS: performance status; OS: overall survival; 1-y SR: 1-year survival rate; ORR: overall response rate. | ||||||||
| Frasci 2001[14] (Lung Cancer) | Traetment | Gemcitabine at 1, 200 mg/m2 on days 1 and 8, every 3 weeks Vinorelbine at 30 mg/m2 on days 1 and 8, every 3 weeks | 60 | ≥70 | 16 | 29 | 30 | 22 |
| Control | Vinorelbine at 30 mg/m2 on days 1 and 8, every 3 weeks | 60 | ≥70 | 13 | 18 | 13 | 15 | |
| Gridelli 2003[15] (J Natl Cancer Inst) | Traetment | Gemcitabine at 1, 000 mg/m2 on days 1 and 8, every 3 weeks Vinorelbine at 25 mg/m2 on days 1 and 8, every 3 weeks | 232 | ≥70 | 44 | 30 | 30 | 21 |
| Control | Gemcitabine at 1, 200 mg/m2 on days 1 and 8, every 3 weeks | 233 | ≥70 | 41 | 28 | 28 | 16 | |
| Traetment | Gemcitabine at 1, 000 mg/m2 on days 1 and 8, every 3 weeks Vinorelbine at 25 mg/m2 on days 1 and 8, every 3 weeks | 232 | ≥70 | 44 | 30 | 30 | 21 | |
| Control | Vinorelbine at 30 mg/m2 on days 1 and 8, every 3 weeks | 233 | ≥70 | 45 | 36 | 38 | 18 | |
| Comella 2004[16] (Br J Cancer) | Traetment | Gemcitabine at 1, 000→1, 200 mg/m2 on days 1 and 8, every 3 weeks Vinorelbine at 25→30 mg/m2 on days 1 and 8, every 3 weeks | 68 | ≥70 | 21 | 9.7 | 32 | 23 |
| Control | Gemcitabine at 1, 200→1, 400→1, 600 mg/m2 on days 1 and 8 and 15, every 4 weeks | 68 | ≥70 | 19 | 5.1 | 29 | 18 | |
| Traetment | Gemcitabine at 1, 000→1, 200 mg/m2 on days 1 and 8, every 3 weeks Vinorelbine at 25→30 mg/m2 on days 1 and 8, every 3 weeks | 68 | ≥70 | 21 | 9.7 | 32 | 23 | |
| Control | Paclitaxei at 100→120→140 mg/m2 on days 1, 8 and 15, every 4 weeks | 63 | ≥70 | 22 | 6.4 | 25 | 13 | |
| Traetment | Gemcitabine at 1, 000→1, 200 mg/m2 on days 1 and 8, every 3 weeks Paclitaxei at 80→100 mg/m2 on days 1 and 8, every 3 weeks | 65 | ≥70 | 15 | 9.2 | 44 | 32 | |
| Control | Gemcitabine at 1, 200→1, 400→1, 600 mg/m2 on days 1, 8 and 15, every 4 weeks | 68 | ≥70 | 19 | 5.1 | 29 | 18 | |
| Traetment | Gemcitabine at 1, 000→1, 200 mg/m2 on days 1 and 8, every 3 weeks Paclitaxei at 80→100 mg/m2 on days 1 and 8, every 3 weeks | 65 | ≥70 | 15 | 9.2 | 44 | 32 | |
| Control | Paclitaxei at 100→120→140 mg/m2 on days 1, 8 and 15 every 4 weeks | 63 | ≥70 | 22 | 5.1 | 25 | 13 | |
| Sun Q 2006[17] (Chin J Geriatr) | Traetment | Gemcitabine at 1, 000 mg/m2 on days 1 and 8, every 3 weeks Cisplatin at 20 mg/m2 on days 1 to 3, every 3 weeks | 22 | ≥70 | 8 | 9.2 | 45.5 | 40.9 |
| Control | Vinorelbine at 25 mg/m2 on days 1 and 8, every 3 weeks | 23 | ≥70 | 9 | 8.8 | 43.5 | 34.9 | |
| Zhang K 2006[18] (Chin J Clin Oncol) | Traetment | Paclitaxel at 60 mg/m2 on days 1, 8 and 15, every 4 weeks Cisplatin at 30 mg/m2 on days 2 to 4, every 4 weeks | 34 | ≥65 | - | 9 | 38.2 | 55.9 |
| Control | Paclitaxel at 60 mg/m2 on days 1, 8 and 15, every 4 weeks | 30 | ≥65 | - | 8 | 36.7 | 26.7 | |
| Traetment | Paclitaxel at 60 mg/m2 on days 1, 8 and 15, every 4 weeks Carboplatin at 5 AUC on days 2, every 4 weeks | 32 | ≥65 | - | 10 | 43.8 | 56.3 | |
| Control | Paclitaxel at 60 mg/m2 on days 1, 8 and 15, every 4 weeks | 30 | ≥65 | - | 8 | 36.7 | 26.7 | |
| Hainsworth 2007[19] (Cancer) | Traetment | Docetaxel at 30 mg/m2 on days 1, 8 and 15, every 4 weeks Gemcitabine at 800 mg/m2 on days 1 and 8 and 15, every 4 weeks | 174 | > 65 | 65 | 5.5 | 26 | 25 (126) |
| Control | Docetaxel at 36 mg/m2 on days 1, 8 and 15, every 4 weeks | 171 | > 65 | 57 | 5.1 | 24 | 17 (130) | |
| Huang C 2007[20] (J Tianjin Med University) | Traetment Control | Vinorelbine at 25 mg/m2 on days 1 and 5, every 3 weeks Cisplatin at 20 mg/m2 on days 2 to 4, every 3 weeks Vinorelbine at 25 mg/m2 on days 1 and 5, every 3 weeks | 28 30 | ≥70 ≥70 | - - | 9.3 9.1 | 46.4 43.3 | 39.3 30 |
| Chen 2008[21] (Lung Cancer) | Traetment | Vinorelbine at 22.5 mg/m2 on days 1 and 8, every 3 weeks Cisplatin at 50 mg/m2 on days 1, every 3 weeks | 34 | ≥70 | 16 | 11.3 | 47.2 | 32.4 |
| Control | Vinorelbine at 25 mg/m2 on days 1 and 8, every 3 weeks | 31 | ≥70 | 16 | 12 | 50.9 | 16.1 | |
| Li PY 2008[22] (J Clin Pulmonary Med) | Traetment | Paclitaxel at 135 mg/m2 on days 1, every 3 weeks Cisplatin at 20 mg/m2 on days 2 to 4, every 3 weeks | 29 | ≥65 | - | - | 46.4 | 37.9 |
| Control | Paclitaxel at 135 mg/m2 on days 1, every 3 weeks | 29 | ≥65 | - | - | 43.3 | 31 | |
| Jiang JL 2010[23] (Clin J Traditional Med) | Traetment | Paclitaxel at 175 mg/m2 on days 1, every 3 weeks Oxaliplatin at 130 mg/m2 on days 1, every 3 weeks | 18 | ≥70 | 16 | 11.4 | 50 | 44.4 |
| Control | Paclitaxel at 175 mg/m2 on days 1, every 3 weeks | 20 | ≥70 | 16 | 13.2 | 44 | 35 | |
| Lou GY 2010[24] (Natl Med J China) | Traetment | Gemcitabine at 1, 000 mg/m2 on days 1 and 8, every 3 weeks Carboplatin at 5 AUC mg/m2 on days 2, every 3 weeks | 34 | ≥70 | 3 | - | 32 | 41 |
| Control | Gemcitabine at 1, 000 mg/m2 on days 1 and 8, every 3 weeks | 34 | ≥70 | 3 | - | 31 | 38 | |
| Quoix 2011[25] (Lancet) | Traetment | Paclitaxei at 90 mg/m2 on day 1, 8 and 15, every 4 weeks Carboplatin at 6 AUC on day 1, every 4 weeks | 225 | ≥70 | 61 | 10.3 | 44.5 | 27.1 |
| Control | Gemcitabine at 1, 150 mg/m2 on days 1 and 8, every 3 weeks & Vinorelbine at 25 mg/m2 on days 1 and 8, every 3 weeks | 226 | ≥70 | 62 | 6.2 | 25.4 | 10.2 | |